Floatz logo

IMMUNOGLOBULIN G1, ANTI-(HUMAN CD ANTIGEN CD27) (HUMAN MONOCLONAL CDX-1127 CLONE 1F5 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL CDX-1127 CLONE 1F5 .KAPPA.-CHAIN, DIMER

Advanced Breast Carcinoma

Cascadian Therapeutics Inc.monoclonal_antibodyPhase 1Dormant
CC
40/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
25/ 100
Competitive Position
89/ 100

Competitive context

20 Active assets in the Advanced Breast Carcinoma cohort.

Asset / SponsorPhaseRating
Trastuzumab Deruxtecan
SWOG Cancer Research Network
Phase 4BBB
Vinorelbine
Sun Yat-sen University
Phase 3BB
Enzalutamide
Nuvation Bio Inc.
Phase 2BB
Atezolizumab
Dana-Farber Cancer Institute
Phase 3BB
Niraparib
OHSU Knight Cancer Institute
Phase 3BB

View all 23 →

Same molecule, other indications

IMMUNOGLOBULIN G1, ANTI-(HUMAN CD ANTIGEN CD27) (HUMAN MONOCLONAL CDX-1127 CLONE 1F5 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL CDX-1127 CLONE 1F5 .KAPPA.-CHAIN, DIMER is also rated in:

B-cell non-Hodgkin lymphomaDormant
CCC
Indicative ·
51 / 100
View asset →
melanomaDormant
CCC
Indicative ·
49 / 100
View asset →
Advanced Ovarian CarcinomaDormant
CCC
Indicative ·
49 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →